Zhuri D, Dusenkalkan F, Tunca Alparslan G, Gurkan H. A Case of Okur-Chung Neurodevelopmental Syndrome with a Novel, de novo Variant on the
CSNK2A1 Gene in a Turkish Patient.
Mol Syndromol 2024;
15:43-50. [PMID:
38357263 PMCID:
PMC10862324 DOI:
10.1159/000530585]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2022] [Accepted: 04/02/2023] [Indexed: 02/16/2024] Open
Abstract
Introduction
Okur-Chung neurodevelopmental syndrome (OCNDS; #617062) has been associated with heterozygous mutations in the CSNK2A1 gene (*115440) mapped on the chromosome's 20p13 region.
Case Presentation
The analysis was performed on a 2-year-old patient who was admitted to our genetic diseases evaluation center by his family with a complaint of hypotonia. We detected a heterozygous NM_177559.3 (CSNK2A1):c.1139_1140dupGG (p.Met381GlyfsTer32) variant in the CSNK2A1 gene from a whole-exome sequence analysis.
Conclusion
The variant that we detected has not been reported in open-access databases to date, so it was evaluated as a novel likely pathogenic variant according to the ACMG-2015 criteria. No variant was detected upon segregation analysis of the patient's parents; therefore, the related variant was evaluated as de novo. In this study, we offer the first report of a pathogenic frameshift variant in the CSNK2A1 gene that has a relationship with OCNDS.
Collapse